Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 3,213 | 3,710 | 3,768 | 4,048 | 3,848 |
| Operating Income | -3,213 | -3,710 | -3,768 | -4,048 | -3,848 |
| Other Income | 250 | 227 | 137 | 180 | 431 |
| Pre-tax Income | -2,963 | -3,483 | -3,631 | -3,868 | -3,417 |
| Net Income Continuous | -2,963 | -3,483 | -3,631 | -3,868 | -3,417 |
| Net Income | $-2,963 | $-3,483 | $-3,631 | $-3,868 | $-3,417 |
| EPS Basic Total Ops | -0.76 | -0.20 | -1.04 | -1.12 | -0.80 |
| EPS Basic Continuous Ops | -0.80 | -0.20 | -1.02 | -1.09 | -0.82 |
| EPS Diluted Total Ops | -0.76 | -0.20 | -1.04 | -1.12 | -0.80 |
| EPS Diluted Continuous Ops | -0.80 | -0.20 | -1.02 | -1.09 | -0.82 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -0.80 | -1.04 | N/A | N/A |
| EBITDA(a) | $-3,213 | $-3,710 | $-3,768 | $-4,048 | $-3,832 |